Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 89
Filtrar
1.
Heliyon ; 10(18): e37425, 2024 Sep 30.
Artigo em Inglês | MEDLINE | ID: mdl-39315184

RESUMO

Fruit crops are essential for human nutrition and health, yet high level of heavy metal levels in soils can degrade fruit quality. These metals accumulate in plant roots and tissues due to factors like excessive fertilizer and pesticide use, poor waste management, and unscientific agricultural practices. Such accumulation can adversely affect plant growth, physiology, and yield. Consuming fruits contaminated with toxic metals poses significant health risks, including nervous system disorders and cancer. Various strategies, such as organic manuring, biomaterials, and modified cultivation practices have been widely researched to reduce heavy metal accumulation. Recently, silicon (Si) application has emerged as a promising and cost-effective solution for addressing biological and environmental challenges in food crops. Si, which can be applied to the soil, through foliar application or a combination of both, helps reduce toxic metal concentrations in soil and plants. Despite its potential, there is currently no comprehensive review that details Si's role in mitigating heavy metal stress in fruit crops. This review aims to explore the potential of Si in reducing heavy metal-induced damage in fruit crops while enhancing growth by alleviating heavy metal toxicity.

2.
Mil Med Res ; 11(1): 67, 2024 Sep 26.
Artigo em Inglês | MEDLINE | ID: mdl-39327610

RESUMO

Nuclear receptors (NRs) function as crucial transcription factors in orchestrating essential functions within the realms of development, host defense, and homeostasis of body. NRs have garnered increased attention due to their potential as therapeutic targets, with drugs directed at NRs demonstrating significant efficacy in impeding chronic disease progression. Consequently, these pharmacological agents hold promise for the treatment and management of various diseases. Accumulating evidence emphasizes the regulatory role of exosome-derived microRNAs (miRNAs) in chronic inflammation, disease progression, and therapy resistance, primarily by modulating transcription factors, particularly NRs. By exploiting inflammatory pathways such as protein kinase B (Akt)/mammalian target of rapamycin (mTOR), nuclear factor kappa-B (NF-κB), signal transducer and activator of transcription 3 (STAT3), and Wnt/ß-catenin signaling, exosomes and NRs play a pivotal role in the panorama of development, physiology, and pathology. The internalization of exosomes modulates NRs and initiates diverse autocrine or paracrine signaling cascades, influencing various processes in recipient cells such as survival, proliferation, differentiation, metabolism, and cellular defense mechanisms. This comprehensive review meticulously examines the involvement of exosome-mediated NR regulation in the pathogenesis of chronic ailments, including atherosclerosis, cancer, diabetes, liver diseases, and respiratory conditions. Additionally, it elucidates the molecular intricacies of exosome-mediated communication between host and recipient cells via NRs, leading to immunomodulation. Furthermore, it outlines the implications of exosome-modulated NR pathways in the prophylaxis of chronic inflammation, delineates current limitations, and provides insights into future perspectives. This review also presents existing evidence on the role of exosomes and their components in the emergence of therapeutic resistance.


Assuntos
Exossomos , Receptores Citoplasmáticos e Nucleares , Humanos , Exossomos/metabolismo , Doença Crônica , Receptores Citoplasmáticos e Nucleares/fisiologia , Receptores Citoplasmáticos e Nucleares/metabolismo , Transdução de Sinais/fisiologia , MicroRNAs
3.
Life Sci ; 354: 122943, 2024 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-39117139

RESUMO

Despite significant advancements in chemotherapy, effective treatments for advanced cancer stages remain largely elusive due to chemoresistance. Resistance to anticancer agents in cancer cells can arise through various mechanisms, including multi-drug resistance, inhibition of apoptosis, modification of drug targets, and enhancement of DNA repair capabilities. Consequently, there is a critical need for agents that can suppress the molecular signatures responsible for drug resistance. Piperine, an active alkaloid extracted from Piper nigrum L. (black pepper), is one such agent that has been extensively studied for its potential in addressing chronic diseases, including cancer. Piperine's antineoplastic properties are mediated through the regulation of numerous key cellular signaling pathways and the modulation of various biological processes. Its capability to enhance drug bioavailability and counteract mechanisms of drug resistance, such as the inhibition of P-glycoprotein (P-gp) and multidrug resistance-associated protein 1 (MRP-1), emphasizes its potential as an adjunct in cancer therapy. Research across various cancer types has demonstrated piperine's role in chemosensitization by targeting P-gp and MRP-1 and altering drug-metabolizing enzymes. This review provides a comprehensive analysis of piperine's pharmacological characteristics and its capacity to modulate several cellular signaling pathways involved in drug resistance. Furthermore, the review emphasizes how piperine, when used in conjunction with other chemotherapeutic agents or natural compounds, can enhance therapeutic effects, leading to improved outcomes in cancer treatment.


Assuntos
Alcaloides , Benzodioxóis , Resistencia a Medicamentos Antineoplásicos , Neoplasias , Piperidinas , Alcamidas Poli-Insaturadas , Alcamidas Poli-Insaturadas/farmacologia , Benzodioxóis/farmacologia , Benzodioxóis/uso terapêutico , Humanos , Piperidinas/farmacologia , Piperidinas/uso terapêutico , Alcaloides/farmacologia , Neoplasias/tratamento farmacológico , Neoplasias/patologia , Resistencia a Medicamentos Antineoplásicos/efeitos dos fármacos , Antineoplásicos/farmacologia , Antineoplásicos/uso terapêutico , Animais , Sinergismo Farmacológico , Membro 1 da Subfamília B de Cassetes de Ligação de ATP/metabolismo , Piper nigrum/química
4.
Int J Biol Macromol ; 278(Pt 2): 134528, 2024 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-39111499

RESUMO

Additive manufacturing can develop regenerative scaffolds for wound healing. 3D printing offers meticulous porosity, mechanical integrity, cell adhesion and cost-effectiveness. Herein, we prepared ink composed of carboxymethyl cellulose (CMC), polyvinylpyrrolidone (PVP), collagen, and oregano extract for the fabrication of tissue constructs. The blend was optimized to form a homogeneous ink and rheological characterization demonstrated shear thinning behavior. The scaffolds were printed using Direct Ink Write (DIW) at a flow speed of 4 mm3/s and a layer height of 0.18 mm. The fabricated scaffolds demonstrated an ultimate tensile strength (UTS) and toughness of 730 KPa and 2.72 MJ/m3, respectively. Scanning Electron Microscopy (SEM) revealed an average pore size of 300 ± 30 µm. Fourier transform infrared spectroscopy (FTIR) analysis confirmed that all materials were present. The contact angle of the composite scaffold was 68° ± 1°. Moreover, the scaffolds presented 82 % mass loss (degradation) in phosphate buffer saline (PBS) over 14 days. The composite scaffold exhibited inhibition zones of 9 mm and 12 mm against Staphylococcus aureus and Escherichia coli, respectively. The PVP/CMC/collagen/oregano 3D printed scaffolds exhibited excellent biocompatibility with the mesenchymal stem cells and humman dermal fibroblast cells, confirmed by water-soluble tetrazolium - 8 (WST-8) assay (test conducted for 7 days). The enhanced angiogenic potential of said scaffold was assesed by release of vascular endothelial growth factor followed by further validation through in-vivo CAM assay. Thus, confirming suitability for the potential wound healing application.


Assuntos
Carboximetilcelulose Sódica , Colágeno , Origanum , Povidona , Alicerces Teciduais , Cicatrização , Povidona/química , Cicatrização/efeitos dos fármacos , Carboximetilcelulose Sódica/química , Carboximetilcelulose Sódica/farmacologia , Alicerces Teciduais/química , Colágeno/química , Colágeno/farmacologia , Humanos , Origanum/química , Staphylococcus aureus/efeitos dos fármacos , Impressão Tridimensional , Materiais Biocompatíveis/química , Materiais Biocompatíveis/farmacologia , Escherichia coli/efeitos dos fármacos , Tinta , Fibroblastos/efeitos dos fármacos , Fibroblastos/citologia , Células-Tronco Mesenquimais/efeitos dos fármacos , Células-Tronco Mesenquimais/citologia , Antibacterianos/farmacologia , Antibacterianos/química , Porosidade , Resistência à Tração , Animais
5.
Environ Technol ; : 1-14, 2024 Jul 07.
Artigo em Inglês | MEDLINE | ID: mdl-38972299

RESUMO

Crude oil spills significantly impact aquatic ecosystems, necessitating innovative remediation strategies. Microalgae-based bioremediation, particularly with Chlorella vulgaris, offers a promising solution. This study introduces a novel framework that evaluates the combined effects of selected environmental stressors on microalgal adaptability, advancing beyond traditional isolated factor analyses. By integrating a factorial experimental design with a machine learning approach using PyCaret AutoML and SHAP values, we provide a detailed examination of how crude oil concentration, salinity, and exposure duration affect C. vulgaris growth. The Extra Trees Regressor model emerged as highly accurate in predicting biomass concentration, a crucial adaptability indicator, achieving an MAE of 0.0202, RMSE of 0.029, and an R² of 0.8875. SHAP analysis highlighted salinity and crude oil as significant growth influencers, with exposure duration playing a minor role. Notably, C. vulgaris exhibited more sensitivity to salinity than to crude oil, indicating potential high-salinity challenges but also a strong tolerance to oil pollutants. These findings enhance our understanding of microalgal responses in polluted environments and suggest improved bioremediation approaches for saline waters affected by oil spills, leveraging the synergy of environmental factors and machine learning insights.

6.
Life Sci ; 352: 122899, 2024 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-38992574

RESUMO

This comprehensive review provides an in-depth analysis of how nanotechnology has revolutionized cancer theragnostic, which combines diagnostic and therapeutic methods to customize cancer treatment. The study examines the unique attributes, uses, and difficulties linked to different types of nanoparticles, including gold, iron oxide, silica, Quantum dots, Carbon nanotubes, and liposomes, in the context of cancer treatment. In addition, the paper examines the progression of nanotheranostics, emphasizing its uses in precise medication administration, photothermal therapy, and sophisticated diagnostic methods such as MRI, CT, and fluorescence imaging. Moreover, the article highlights the capacity of nanoparticles to improve the effectiveness of drugs, reduce the overall toxicity in the body, and open up new possibilities for treating cancer by releasing drugs in a controlled manner and targeting specific areas. Furthermore, it tackles concerns regarding the compatibility of nanoparticles and their potential harmful effects, emphasizing the significance of continuous study to improve nanotherapeutic methods for use in medical treatments. The review finishes by outlining potential future applications of nanotechnology in predictive oncology and customized medicine.


Assuntos
Sistemas de Liberação de Medicamentos , Nanopartículas , Neoplasias , Humanos , Neoplasias/tratamento farmacológico , Sistemas de Liberação de Medicamentos/métodos , Nanomedicina Teranóstica/métodos , Animais , Antineoplásicos/administração & dosagem , Antineoplásicos/uso terapêutico , Nanotecnologia/métodos
7.
Artigo em Inglês | MEDLINE | ID: mdl-38982696

RESUMO

Lymphoma is a malignant tumor caused by abnormal proliferation of lymphocytes in the lymphatic system. Conventional treatments for lymphoma often have limitations, and new therapeutic strategies need to be explored. Realgar is an ancient Chinese medicine that has been used for centuries to treat a variety of ailments due to its therapeutic potential for various diseases, including cancer. However, it is a time-consuming waste and has a low absorption rate in the gastrointestinal tract, so it has the disadvantages of oral dose, potential toxicity, and low bioavailability. Recently, the development of nanotechnology has promoted the nanization of realgar particles, which have better physicochemical properties and higher bioavailability. The antitumor activity of Realgar nanoparticles against lymphoma has been demonstrated in preclinical studies. Realgar nanoparticles exhibit cytotoxic effects by inducing apoptosis and inhibiting the growth and proliferation of lymphoma cells. Moreover, these nanoparticles exert immunomodulatory effects by enhancing the activity of immune cells and promoting the cytotoxicity of T lymphocytes against lymphoma cells. Additionally, realgar nanoparticles have been shown to inhibit tumor angiogenesis, thereby restricting the blood supply and nutrient availability to lymphoma cells. Despite promising preclinical data, further research on the role and mechanism of realgar nanoparticles in the treatment of lymphoma remains to be studied. Moreover, the translation of these findings into clinical practice requires rigorous evaluation through well-designed clinical trials. Realgar nanoparticles hold great potential as a novel therapeutic approach for lymphoma, and their development may contribute to the advancement of precision medicine in the field of oncology.

8.
Heliyon ; 10(11): e32484, 2024 Jun 15.
Artigo em Inglês | MEDLINE | ID: mdl-38961896

RESUMO

In the present study, we prepared magnetite nanoparticles (MNPs) loaded with natural Moringa oleifera (M. olf) herb and Epilim (Ep) drug to evaluate the anti-cancerous activity against brain cancer cells. All the samples were prepared via co-precipitation approach modified with different concentrations of M. olf and Ep drug at room temperature. The MNPs loaded with drug and natural herb were studied in terms of crystal structure, morphology, colloidal stability, size distribution, and magnetic properties. Field emission scanning electron microscopy (FESEM) images exhibited the morphologies of samples with spherical shape as well as the particles size of 9 nm for MNPs and up to 23 nm for its composites. The results of vibrating sample magnetometer (VSM) indicated the magnetization saturation (Ms) of 42.510 emu/g for MNPs. This value reduced to 16-35 emu/g upon loading MNPs with different concentrations of M. olf and Ep. Fourier transform infrared spectroscopy (FTIR) indicated the chemical interaction between the Ep, M.olf and MNPs. Brunauer-Emmett-Teller (BET) analysis confirmed the largest surface area for MNPs (422.61 m2/g) which gradually reduced on addition of M. olf and Ep indicating the successful loading. The zeta potential measurements indicated that the MNPs and MNPs loaded with M. olf and Ep are negatively charged and can be dispersed in the suspension. Furthermore, U87 human glioblastoma cell line was used for the in vitro cellular studies to determine the efficacy of synthesized MNPs against cancer cells. The results confirmed the anti-proliferative activity of the MNPs loaded with M. olf and Ep.

9.
BMJ Open ; 14(7): e081821, 2024 Jul 09.
Artigo em Inglês | MEDLINE | ID: mdl-38986553

RESUMO

INTRODUCTION: Morbidity from an emergency laparotomy (EmLap) is difficult to define and poorly understood. Morbidity is a holistic concept, reliant upon an interplay of bio-psychosocial outcomes that evolve long after discharge. To date, no previous study has explored the psychosocial outcomes following EmLap as a collective, nor their change over time. This study aims to describe the holistic morbidity following EmLap within the first year following surgery. METHODS AND ANALYSIS: This is a multicentre, mixed-methods prospective 12-month cohort study with two participant populations: patient participants and family caregivers (FCGs). A target of 160 adult patients who undergo EmLap and can give informed consent will be included in the patient participant group. Patient participants will be asked to complete three patient surveys, incorporating validated patient-reported outcome measures (PROMs) to assess bio-psychosocial outcomes (EuroQol five-dimension five-level (EQ5D-5L), Gastrointestinal Quality Life Index-36, Patient Health Questionnaire-9, Generalised Anxiety Disorder 7, International Trauma Questionnaire, Caregiver Interaction Scale and Fatigue Severity Scale) in the 12 months following surgery. A subgroup of 15 patient participants will be asked to take part in two semistructured interviews at 6 and 12 months. A target of 15 associated family caregivers will be included in the FCG group. FCGs will be asked to take part in a semi-structured interview at 6 months to assess the EmLap impact on the wider support network. The primary outcome will be a change in quality of life (EQ5D-5L) at 12 months. Secondary outcomes will be changes in bio-psychosocial status at 3 and 12 months. Qualitative analysis will allow contextualisation of PROMS and further explore themes of EmLap morbidity. It is anticipated that the results of this study will help inform and develop standards of aftercare for future EmLap patients. ETHICS AND DISSEMINATION: This study has received ethical approval (Wales REC7;12/WA/0297) and will be undertaken in accordance with the principles of Good Clinical Practice. We intend to disseminate study results in peer-reviewed journals and medical conferences, as well as a lay report to study participants. TRIAL REGISTRATION NUMBER: Clinical Trials.gov NCT05281627.


Assuntos
Laparotomia , Qualidade de Vida , Humanos , Laparotomia/psicologia , Estudos Prospectivos , Adulto , Medidas de Resultados Relatados pelo Paciente , Cuidadores/psicologia , Emergências/psicologia , Feminino , Masculino , Projetos de Pesquisa , Inquéritos e Questionários , Estudos Multicêntricos como Assunto , Complicações Pós-Operatórias/psicologia
10.
Front Oncol ; 14: 1383939, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-39077471

RESUMO

Ovarian cancer (OVC) is one of the most common causes of cancer-related deaths in women worldwide. Despite advancements in detection and therapy, the prognosis of OVC remains poor due to late diagnosis and the lack of effective therapeutic options at advanced stages. Therefore, a better understanding of the biology underlying OVC is essential for the development of effective strategies for early detection and targeted therapies. Nuclear receptors (NRs) are a superfamily of 48 transcription factors that, upon binding to their specific ligand, play a vital role in regulating various cellular processes such as growth, development, metabolism, and homeostasis. Accumulating evidence from several studies has shown that their aberrant expression is associated with multiple human diseases. Numerous NRs have shown significant effects in the development of various cancers, including OVC. This review summarizes the recent findings on the role of NRs in OVC, as well as their potential as prognostic and therapeutic markers. Further, the basic structure and signaling mechanism of NRs have also been discussed briefly. Moreover, this review highlights their cellular and molecular mechanisms in chemoresistance and chemosensitization. Further, the clinical trials targeting NRs for the treatment of OVC have also been discussed.

11.
Life Sci ; 351: 122786, 2024 Aug 15.
Artigo em Inglês | MEDLINE | ID: mdl-38848944

RESUMO

Gangliosides represent glycolipids containing sialic acid residues, present on the cell membrane with glycan residues exposed to the extracellular matrix (ECM), while the ceramides are anchored within the membrane. These molecules play a critical role in pathophysiological processes such as host-pathogen interactions, cell-cell recognition, signal transduction, cell adhesion, motility, and immunomodulation. Accumulated evidence suggests the overexpression of gangliosides on tumor tissues in comparison to healthy human tissues. These tumor-associated gangliosides have been implicated in various facets of tumor biology, including cell motility, differentiation, signaling, immunosuppression, angiogenesis, and metastasis. Consequently, these entities emerge as attractive targets for immunotherapeutic interventions. Notably, the administration of antibodies targeting gangliosides has demonstrated cytotoxic effects on cancer cells that exhibit an overexpression of these glycolipids. Passive immunotherapy approaches utilizing murine or murine/human chimeric anti-ganglioside antibodies have been explored as potential treatments for diverse cancer types. Additionally, vaccination strategies employing tumor-associated gangliosides in conjunction with adjuvants have entered the realm of promising techniques currently undergoing clinical trials. The present comprehensive review encapsulates the multifaceted roles of gangliosides in tumor initiation, progression, immunosuppression, and metastasis. Further, an overview is provided of the correlation between the expression status of gangliosides in normal and tumor cells and its impact on cancer patient survival. Furthermore, the discussion extends to ongoing and completed clinical trials employing diverse strategies to target gangliosides, elucidating their effectiveness in treating cancers. This emerging discipline is expected to supply substantial impetus for the establishment of novel therapeutic strategies.


Assuntos
Gangliosídeos , Imunomodulação , Imunoterapia , Neoplasias , Humanos , Gangliosídeos/imunologia , Neoplasias/imunologia , Neoplasias/terapia , Animais , Imunoterapia/métodos
12.
Life Sci ; 351: 122785, 2024 Aug 15.
Artigo em Inglês | MEDLINE | ID: mdl-38851420

RESUMO

Lung cancer stands as one of the most lethal diseases and is the foremost cause of cancer-related mortalities worldwide. The pathophysiology of lung cancer is multifaceted, and it includes multiple cell signaling pathways and other complex factors such as oxidative stress and genetics. The association of HPV with lung carcinogenesis was first proposed in 1979, and since then, scientists worldwide have been putting forward several hypotheses to establish a relationship between this virus and lung cancer. Although studies have reported the presence of HPV in lung cancer, the exact mechanism of entry and the route of transmission have not been elucidated clearly till date. Numerous studies across the globe have detected differentially expressed HPV oncoproteins in lung cancer patients and found their association with the critical cell signaling pathways that leads to the development and progression of lung cancer. Many reports have also provided evidence stating the involvement of HPV in determining the survival status of lung cancer patients. The present review recapitulates the studies evincing the association of HPV and lung cancer, its route of transmission and mechanism of action; the detection of the virus and treatment opportunities for HPV-positive lung cancer; and the severity associated with this disease. Therefore, this will provide an explicit idea and would help to develop preventive measures and specific as well as effective treatment for HPV-associated lung carcinogenesis.


Assuntos
Neoplasias Pulmonares , Papillomaviridae , Infecções por Papillomavirus , Humanos , Neoplasias Pulmonares/virologia , Infecções por Papillomavirus/virologia , Infecções por Papillomavirus/complicações , Papillomaviridae/patogenicidade , Carcinogênese , Papillomavirus Humano
13.
Cancer Lett ; 597: 217019, 2024 Aug 10.
Artigo em Inglês | MEDLINE | ID: mdl-38849013

RESUMO

Despite considerable progress in cancer treatment options, resistance to chemotherapeutic drugs remains a significant challenge. This review focuses on Berberine (BBR), an isoquinoline alkaloid found in various medicinal plants, which has garnered attention in the field of oncology for its anticancer potential either alone or in combination with other compounds and its ability to modulate chemoresistance, acting as a natural chemosensitizer. BBR's ability to modulate chemoresistance is attributed to its diverse mechanisms of action, including inducing DNA breaks, inhibition of drug efflux pumps, modulation of apoptosis and necroptosis, downregulating multidrug resistance genes, enhancing immune response, suppressing angiogenesis and targeting multiple pathways within cancer cells, including protein kinase B/mammalian target of rapamycin (Akt/mTOR), epidermal growth factor receptor (EGFR), mitogen-activated protein kinase (MAPK), nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), poly(ADP-ribose) polymerase (PARP1), janus kinase/signal transducers and activators of transcription (JAK-STAT), Wnt/ß-catenin etc. Moreover, BBR, in combination with other compounds, also offers a promising approach to cancer therapy, enforcing its broad-spectrum anticancer effects. Therefore, this review aims to elucidate the intricate mechanism of action of BBR in combinatorial therapy as a potential chemosensitizer to increase the efficiency of several drugs, including cisplatin, doxorubicin, lapatinib, tamoxifen, irinotecan, niraparib, etc. in various cancers. Additionally, this review briefly covers the origin and biological activities of BBR, exploring the specific actions underlying its anticancer effects. Further, pharmacokinetic properties of BBR are also discussed, providing insight into its therapeutic potential and optimization of its use in cancer treatment.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica , Berberina , Resistencia a Medicamentos Antineoplásicos , Neoplasias , Humanos , Berberina/farmacologia , Berberina/uso terapêutico , Neoplasias/tratamento farmacológico , Neoplasias/patologia , Resistencia a Medicamentos Antineoplásicos/efeitos dos fármacos , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Protocolos de Quimioterapia Combinada Antineoplásica/farmacologia , Animais , Transdução de Sinais/efeitos dos fármacos
14.
Int J Phytoremediation ; 26(12): 1914-1922, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38847151

RESUMO

Crude oil spills imperil aquatic ecosystems globally, prompting innovative solutions such as microalgae-based bioremediation. This study explores the potential of Chlorella vulgaris and Scenedesmus quadricauda, for crude oil spill phycoremediation under mixotrophic conditions and varying crude oil concentrations (0.5-2%). C. vulgaris demonstrated notable resilience, thriving up to 1% crude oil exposure, while S. quadricauda adapted to lower concentrations. Optimal growth for both was observed at 0.5% exposure. Chlorophyll a content in C. vulgaris increases at 0.5% exposure but declines above 1%, while a decline was noticeable in chlorophyll b in treatment groups above 1%. Carotenoid levels varied, displaying the highest levels at higher concentrations above 1.5%. Similarly, S. quadricauda showed increased chlorophyll a content at 0.5% exposure, with stable carotenoid levels and a decline in chlorophyll b content at higher concentrations. GC/MS analyses indicated C. vulgaris efficiently degraded aliphatic compounds like decane and tridecane, surpassing S. quadricauda in degrading both aliphatic and aromatic hydrocarbons. Growth kinetics was best represented by the modified Gompertz and logistic models. These findings highlight the species-specific adaptability and optimal concentration for microalgae to degrade crude oil effectively, advancing phycoremediation processes and strategies critical for environmental restoration.


This study marks the first exploration of both Chlorella vulgaris and the previously unexplored Scenedesmus quadricauda for crude oil phycoremediation potential under mixotrophic conditions. Additionally, it pioneers the modeling and study of algae growth kinetics in response to crude oil exposure. Notably, this research demonstrated the adaptability and efficiency of C. vulgaris in degrading crude oil components under mixotrophic conditions up to a level of 1%, while S. quadricauda showed similar capabilities at a concentration of 0.5%.


Assuntos
Biodegradação Ambiental , Chlorella vulgaris , Hidrocarbonetos , Petróleo , Scenedesmus , Poluentes Químicos da Água , Chlorella vulgaris/metabolismo , Scenedesmus/metabolismo , Petróleo/metabolismo , Poluentes Químicos da Água/metabolismo , Hidrocarbonetos/metabolismo , Cinética , Poluição por Petróleo , Clorofila A/metabolismo , Clorofila/metabolismo , Microalgas/metabolismo
15.
PLoS One ; 19(5): e0298256, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38753701

RESUMO

The study of thermal therapy to tumors and the response of living cells to this therapy used to treat tumor is very important due to the complexity of heat transfer in biological tissues. In the past few years, there has been a growing interest among clinicians, mathematicians, and engineers regarding the use of computational and mathematical methods to simulate biological systems. Numerous medical proceedings also employ mathematical modeling and engineering techniques as a means to guarantee their safety and evaluate the associated risks effectively. This manuscript provides an analytical solution used for the first time to study the mechanism of biological thermal response during heat therapy on spheroidal skin tumor. The proposed method used a generalized thermoelasticity model with one relaxation time. The influence of relaxation times on the responses of diseased and healthy tissues is studied and interpreted graphically. Also, the impact of different laser irradiance on the thermal profile of the malignant tumor cells over a period of 2 minutes is interpreted graphically. To investigate the transfer of heat within biological tissues during the thermal therapy, the Laplace transform and inverse Laplace transform methods were applied. A comparison of the present generalized thermoelasticity model and different models based on Pennes bioheat transfer PBT shows that our proposed model yields more realistic and accurate predictions. The current model can be used to explain various therapeutic methods.


Assuntos
Temperatura Alta , Hipertermia Induzida , Neoplasias Cutâneas , Humanos , Neoplasias Cutâneas/terapia , Neoplasias Cutâneas/patologia , Hipertermia Induzida/métodos , Temperatura Alta/uso terapêutico , Modelos Biológicos , Modelos Teóricos
16.
Pharmacol Res ; 203: 107167, 2024 May.
Artigo em Inglês | MEDLINE | ID: mdl-38599470

RESUMO

Cancer has become a burgeoning global healthcare concern marked by its exponential growth and significant economic ramifications. Though advancements in the treatment modalities have increased the overall survival and quality of life, there are no definite treatments for the advanced stages of this malady. Hence, understanding the diseases etiologies and the underlying molecular complexities, will usher in the development of innovative therapeutics. Recently, YAP/TAZ transcriptional regulation has been of immense interest due to their role in development, tissue homeostasis and oncogenic transformations. YAP/TAZ axis functions as coactivators within the Hippo signaling cascade, exerting pivotal influence on processes such as proliferation, regeneration, development, and tissue renewal. In cancer, YAP is overexpressed in multiple tumor types and is associated with cancer stem cell attributes, chemoresistance, and metastasis. Activation of YAP/TAZ mirrors the cellular "social" behavior, encompassing factors such as cell adhesion and the mechanical signals transmitted to the cell from tissue structure and the surrounding extracellular matrix. Therefore, it presents a significant vulnerability in the clogs of tumors that could provide a wide window of therapeutic effectiveness. Natural compounds have been utilized extensively as successful interventions in the management of diverse chronic illnesses, including cancer. Owing to their capacity to influence multiple genes and pathways, natural compounds exhibit significant potential either as adjuvant therapy or in combination with conventional treatment options. In this review, we delineate the signaling nexus of YAP/TAZ axis, and present natural compounds as an alternate strategy to target cancer.


Assuntos
Neoplasias , Fatores de Transcrição , Proteínas com Motivo de Ligação a PDZ com Coativador Transcricional , Proteínas de Sinalização YAP , Animais , Humanos , Antineoplásicos/uso terapêutico , Antineoplásicos/farmacologia , Produtos Biológicos/uso terapêutico , Produtos Biológicos/farmacologia , Neoplasias/tratamento farmacológico , Neoplasias/metabolismo , Neoplasias/patologia , Transdução de Sinais/efeitos dos fármacos , Transativadores/metabolismo , Fatores de Transcrição/metabolismo , Proteínas com Motivo de Ligação a PDZ com Coativador Transcricional/metabolismo , Proteínas de Sinalização YAP/metabolismo
17.
Front Oncol ; 14: 1288501, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38559562

RESUMO

SKP2 (S-phase kinase-associated protein 2) is a member of the F-box family of substrate-recognition subunits in the SCF ubiquitin-protein ligase complexes. It is associated with ubiquitin-mediated degradation in the mammalian cell cycle components and other target proteins involved in cell cycle progression, signal transduction, and transcription. Being an oncogene in solid tumors and hematological malignancies, it is frequently associated with drug resistance and poor disease outcomes. In the current review, we discussed the novel role of SKP2 in different hematological malignancies. Further, we performed a limited in-silico analysis to establish the involvement of SKP2 in a few publicly available cancer datasets. Interestingly, our study identified Skp2 expression to be altered in a cancer-specific manner. While it was found to be overexpressed in several cancer types, few cancer showed a down-regulation in SKP2. Our review provides evidence for developing novel SKP2 inhibitors in hematological malignancies. We also investigated the effect of SKP2 status on survival and disease progression. In addition, the role of miRNA and its associated families in regulating Skp2 expression was explored. Subsequently, we predicted common miRNAs against Skp2 genes by using miRNA-predication tools. Finally, we discussed current approaches and future prospective approaches to target the Skp2 gene by using different drugs and miRNA-based therapeutics applications in translational research.

18.
Cancer Metastasis Rev ; 43(1): 293-319, 2024 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-38438800

RESUMO

Metabolic reprogramming, a hallmark of cancer, allows cancer cells to adapt to their specific energy needs. The Warburg effect benefits cancer cells in both hypoxic and normoxic conditions and is a well-studied reprogramming of metabolism in cancer. Interestingly, the alteration of other metabolic pathways, especially lipid metabolism has also grabbed the attention of scientists worldwide. Lipids, primarily consisting of fatty acids, phospholipids and cholesterol, play essential roles as structural component of cell membrane, signalling molecule and energy reserves. This reprogramming primarily involves aberrations in the uptake, synthesis and breakdown of lipids, thereby contributing to the survival, proliferation, invasion, migration and metastasis of cancer cells. The development of resistance to the existing treatment modalities poses a major challenge in the field of cancer therapy. Also, the plasticity of tumor cells was reported to be a contributing factor for the development of resistance. A number of studies implicated that dysregulated lipid metabolism contributes to tumor cell plasticity and associated drug resistance. Therefore, it is important to understand the intricate reprogramming of lipid metabolism in cancer cells. In this review, we mainly focused on the implication of disturbed lipid metabolic events on inducing tumor cell plasticity-mediated drug resistance. In addition, we also discussed the concept of lipid peroxidation and its crucial role in phenotypic switching and resistance to ferroptosis in cancer cells. Elucidating the relationship between lipid metabolism, tumor cell plasticity and emergence of resistance will open new opportunities to develop innovative strategies and combinatorial approaches for the treatment of cancer.


Assuntos
Metabolismo dos Lipídeos , Neoplasias , Humanos , Plasticidade Celular , Neoplasias/patologia , Resistencia a Medicamentos Antineoplásicos , Colesterol/metabolismo
19.
Cancer Metastasis Rev ; 43(1): 321-362, 2024 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-38517618

RESUMO

Recent advances have brought forth the complex interplay between tumor cell plasticity and its consequential impact on drug resistance and tumor recurrence, both of which are critical determinants of neoplastic progression and therapeutic efficacy. Various forms of tumor cell plasticity, instrumental in facilitating neoplastic cells to develop drug resistance, include epithelial-mesenchymal transition (EMT) alternatively termed epithelial-mesenchymal plasticity, the acquisition of cancer stem cell (CSC) attributes, and transdifferentiation into diverse cell lineages. Nuclear receptors (NRs) are a superfamily of transcription factors (TFs) that play an essential role in regulating a multitude of cellular processes, including cell proliferation, differentiation, and apoptosis. NRs have been implicated to play a critical role in modulating gene expression associated with tumor cell plasticity and drug resistance. This review aims to provide a comprehensive overview of the current understanding of how NRs regulate these key aspects of cancer biology. We discuss the diverse mechanisms through which NRs influence tumor cell plasticity, including EMT, stemness, and metastasis. Further, we explore the intricate relationship between NRs and drug resistance, highlighting the impact of NR signaling on chemotherapy, radiotherapy and targeted therapies. We also discuss the emerging therapeutic strategies targeting NRs to overcome tumor cell plasticity and drug resistance. This review also provides valuable insights into the current clinical trials that involve agonists or antagonists of NRs modulating various aspects of tumor cell plasticity, thereby delineating the potential of NRs as therapeutic targets for improved cancer treatment outcomes.


Assuntos
Plasticidade Celular , Neoplasias , Humanos , Plasticidade Celular/fisiologia , Neoplasias/patologia , Transdução de Sinais , Transição Epitelial-Mesenquimal/fisiologia , Resistencia a Medicamentos Antineoplásicos , Receptores Citoplasmáticos e Nucleares/metabolismo , Células-Tronco Neoplásicas/patologia
20.
Heliyon ; 10(6): e27102, 2024 Mar 30.
Artigo em Inglês | MEDLINE | ID: mdl-38510026

RESUMO

One of the main source of demise during the next ten years will be coronary heart disease and stroke, which are brought on by smoking (nicotine). To identify the percentage (%) of nicotine consumption by electrocatalytic sensor towards nicotine for target-specific prevent stroke, four uninuclear Ni2+ complexes of substituted butanimidamide Schiff base ligands [H2L1-4] was prepared. All the complexes were thoroughly analyzed by using several spectroscopic techniques such as CHNS analysis, FT-IR, NMR (1H & 13C) UV-Vis and NMR. The analyses showed tetradentate binding mode of ligand around nickel(II) metal ion leads to the structure of square planar with N2X2 (X = O, S) donor fashion. In addition, the well-defined nickel(II) complexes were utilized for oxidation of various alcohols such as cyclohexanol, and benzyl alcohol were produced to the assorted oxidized products with high yield respectively using greener co-oxidant (molecular oxygen). In addition, Nickel(II) complexes was further utilized as catalyst for aryl-aryl coupling reaction via Suzuki-Mayura method to obtain biphenyl compound. Furthermore, nickel(II) complexes were exploited for electrochemical detection of nicotine sensing in µM concentration.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA